Who owns Cytomx Therapeutics?
- Ticker: CTMX
- CUSIP Number: 23284f105
Tip: Access positions for across all investors
Analyze quarterly positions in Cytomx Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cytomx Therapeutics stock
Who bought or sold Cytomx Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| VR Adviser | 16M | $50M | 11% | Sep 2025 |
|
| FMR | 15M | $49M | 67% | Sep 2025 |
|
| Tang Capital Management | 11M | $35M | 0% | Sep 2025 |
|
| Perceptive Advisors | 9.7M | $31M | 38% | Sep 2025 |
|
| Vanguard Group | 8.9M | $29M | -5% | Sep 2025 |
|
| OrbiMed Advisors | 8.5M | $27M | 0% | Sep 2025 |
|
| Commodore Capital | 7.7M | $25M | 0% | Sep 2025 |
|
| Balyasny Asset Management | 4.8M | $15M | 68% | Sep 2025 |
|
| Baker Bros. Advisors | 4.3M | $14M | 22% | Sep 2025 |
|
| Point72 Asset Management | 4.1M | $13M | -50% | Sep 2025 |
|
| ADAR1 Capital Management | 4.0M | $13M | 31% | Sep 2025 |
|
| Kynam Capital Management | 3.6M | $12M | 69% | Sep 2025 |
|
| Rtw Investments | 3.5M | $11M | 0% | Sep 2025 |
|
| Ikarian Capital | 3.4M | $11M | 100% | Sep 2025 |
|
| Vivo Capital | 2.9M | $9.2M | -50% | Sep 2025 |
|
| RA Capital Management | 2.7M | $8.5M | 0% | Sep 2025 |
|
| Renaissance Technologies | 2.5M | $8.1M | 37% | Sep 2025 |
|
| BlackRock | 2.4M | $7.6M | 0% | Sep 2025 |
|
| Woodline Partners | 2.3M | $7.5M | 0% | Sep 2025 |
|
| Citadel Advisors | 2.0M | $6.3M | 480% | Sep 2025 |
|
| Geode Capital Management | 1.6M | $5.0M | -10% | Sep 2025 |
|
| Millennium Management | 1.4M | $4.4M | 494% | Sep 2025 |
|
| Financial Engines Advisors L.L.C | 1.4M | $4.4M | 100% | Sep 2025 |
|
| Boothbay Fund Management | 1.2M | $3.9M | 100% | Sep 2025 |
|
| Marshall Wace | 1.1M | $3.5M | -53% | Sep 2025 |
|
| Exome Asset Management | 745k | $2.4M | 100% | Sep 2025 |
|
| Assenagon Asset Management | 730k | $2.3M | 1% | Sep 2025 |
|
| Two Sigma Investments | 730k | $2.3M | 363% | Sep 2025 |
|
| Acadian Asset Management | 654k | $2.1M | -58% | Sep 2025 |
|
| State Street Corporation | 645k | $2.1M | 1% | Sep 2025 |
|
| Susquehanna International | 633k | $2.0M | 95% | Sep 2025 |
|
| Prosight Management | 565k | $1.8M | -84% | Sep 2025 |
|
| GSA Capital Partners | 536k | $1.7M | -15% | Sep 2025 |
|
| CWM Advisors | 523k | $1.7M | 100% | Sep 2025 |
|
| Jane Street | 455k | $1.5M | 511% | Sep 2025 |
|
| Dimensional Fund Advisors | 451k | $1.4M | 146% | Sep 2025 |
|
| Goldman Sachs Group | 448k | $1.4M | 625% | Sep 2025 |
|
| First Trust Advisors | 402k | $1.3M | 100% | Sep 2025 |
|
| Northern Trust | 390k | $1.2M | -13% | Sep 2025 |
|
| Morgan Stanley | 339k | $770k | 100% | Jun 2025 |
|
| Raymond James Financial | 294k | $937k | 4% | Sep 2025 |
|
| HighVista Strategies | 257k | $820k | 100% | Sep 2025 |
|
| Bank of New York Mellon | 253k | $806k | 0% | Sep 2025 |
|
| Caption Management | 250k | $797k | 233% | Sep 2025 |
|
| Precision Wealth Strategies | 237k | $756k | 100% | Sep 2025 |
|
| Springbok Capital Management | 207k | $659k | 100% | Sep 2025 |
|
| Diadema Partners | 185k | $591k | 100% | Sep 2025 |
|
| Ameriprise Financial | 158k | $505k | 100% | Sep 2025 |
|
| Royal Bank of Canada | 152k | $486k | -37% | Sep 2025 |
|
| Stonepine Capital Management | 125k | $399k | 100% | Sep 2025 |
|
| Qube Research & Technologies | 123k | $391k | 100% | Sep 2025 |
|
| BBK Capital Partners | 118k | $378k | -62% | Sep 2025 |
|
| Toroso Investments | 118k | $378k | -62% | Sep 2025 |
|
| Congress Park Capital | 104k | $332k | 9% | Sep 2025 |
|
| Aspire Growth Partners | 102k | $326k | 0% | Sep 2025 |
|
| Charles Schwab Investment Management | 89k | $283k | 0% | Sep 2025 |
|
| LPL Financial | 87k | $276k | -57% | Sep 2025 |
|
| Velan Capital Investment Management | 80k | $255k | 7% | Sep 2025 |
|
| Miller Financial Services | 67k | $214k | 31% | Sep 2025 |
|
| Merit Financial Group | 53k | $170k | 100% | Sep 2025 |
|
| Leucadia National Corporation | 53k | $169k | 100% | Sep 2025 |
|
| Jacobs Levy Equity Management | 51k | $162k | 100% | Sep 2025 |
|
| Susquehanna Portfolio Strategies | 48k | $153k | -52% | Sep 2025 |
|
| Squarepoint Ops | 48k | $152k | -3% | Sep 2025 |
|
| Private Advisor | 44k | $140k | 0% | Sep 2025 |
|
| Two Sigma Advisers | 40k | $128k | 100% | Sep 2025 |
|
| Jain Global | 34k | $107k | 100% | Sep 2025 |
|
| UBS Group | 30k | $96k | -93% | Sep 2025 |
|
| XTX Topco | 29k | $93k | -76% | Sep 2025 |
|
| JustInvest | 27k | $86k | -7% | Sep 2025 |
|
| Ethos Financial Group | 24k | $76k | 100% | Sep 2025 |
|
| Prudential Financial | 23k | $74k | -9% | Sep 2025 |
|
| BlueChip Wealth Advisors | 23k | $73k | 100% | Sep 2025 |
|
| Invesco | 22k | $72k | 58% | Sep 2025 |
|
| Forefront Wealth Partners | 18k | $58k | 100% | Sep 2025 |
|
| Forefront Analytics | 18k | $58k | -35% | Sep 2025 |
|
| Truvestments Capital | 17k | $55k | 15% | Sep 2025 |
|
| Taddei, Ludwig & Associates | 17k | $55k | 0% | Sep 2025 |
|
| Advisor Group Holdings | 17k | $53k | 3% | Sep 2025 |
|
| Jpmorgan Chase & Co | 16k | $52k | -85% | Sep 2025 |
|
| Icapital Wealth | 15k | $46k | 0% | Sep 2025 |
|
| Victory Capital Management | 14k | $45k | 14% | Sep 2025 |
|
| Nierenberg Investment Management Company | 13k | $40k | 0% | Sep 2025 |
|
| Branch Banking & Trust Company | 13k | $13k | 100% | Sep 2025 |
|
| IPG Investment Advisors | 13k | $40k | 0% | Sep 2025 |
|
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 11k | $34k | 100% | Sep 2025 |
|
| Mariner Wealth Advisors | 10k | $33k | 100% | Sep 2025 |
|
| Peregrine Asset Advisers | 10k | $32k | 0% | Sep 2025 |
|
| Meridian Wealth Management | 10k | $32k | 0% | Sep 2025 |
|
| Farther Finance Advisors | 8.0k | $25k | 100% | Sep 2025 |
|
| Private Wealth Asset Management | 4.0k | $13k | 0% | Sep 2025 |
|
| Wells Fargo & Company | 3.6k | $12k | 100% | Sep 2025 |
|
| Barclays | 1.5k | $4.8k | 74400% | Sep 2025 |
|
| Caitong International Asset Management | 689.00 | $2.2k | -58% | Sep 2025 |
|
| Advisory Services Network | 274.00 | $874.005200 | 100% | Sep 2025 |
|
| SBI Securities | 85.00 | $270.997000 | 1% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 17.00 | $54.000500 | 0% | Sep 2025 |
|
| Tower Research Capital | 3.00 | $9.999900 | -100% | Sep 2025 |
|
Who sold out of Cytomx Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Franklin Resources | Jun 2025 | 5.8M | $13M |
| Fairmount Funds Management | Jun 2025 | 3.9M | $8.8M |
| Soleus Capital Management | Jun 2025 | 1.3M | $3.0M |
| Readystate Asset Management | Jun 2025 | 845k | $1.9M |
| Eudaimonia Asset Management | Jun 2025 | 255k | $578k |
| Bridgeway Capital Management | Jun 2025 | 126k | $286k |
| Commonwealth Equity Services | Jun 2025 | 53k | $121k |
| Bayesian Capital Management | Jun 2025 | 50k | $114k |
| Two Sigma Securities | Jun 2025 | 47k | $107k |
| Lazard Asset Management | Jun 2025 | 43k | $98k |
| Virtu Financial | Jun 2025 | 35k | $80k |
| Federated Investors | Jun 2025 | 398.00 | $902.982400 |